2023 Cancer Nanotechnology Gordon Research Conference and Gordon Research Seminar
2023癌症纳米技术戈登研究大会暨戈登研究研讨会
基本信息
- 批准号:10609291
- 负责人:
- 金额:$ 0.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAddressBasic ScienceBiological SciencesCOVID-19 pandemicCancer BiologyCancer ScienceCellular biologyChemistryClinicClinicalClinical ResearchClinical SciencesCollaborationsCommunicationCommunitiesCustomDataDedicationsDevelopmentDiagnosisDiagnosticDrug Delivery SystemsEngineeringEnsureEnvironmentFemaleFosteringFundingGene DeliveryGenerationsGoalsGovernmentGrantHourImageImage-Guided SurgeryImmunologyImmunooncologyIndustryInternationalInterruptionKnowledgeMalignant NeoplasmsMemorial Sloan-Kettering Cancer CenterNanotechnologyNatureNorth CarolinaOralParticipantPersonsPostdoctoral FellowQualifyingRaceRequest for ProposalsResearchResearch PersonnelScheduleScienceScientistSenior ScientistSeriesSpeedStudentsTechnologyTimeTissue EngineeringTrainingTranslational ResearchTranslationsTravelUnited StatesUnited States National Institutes of HealthWomanWorkanticancer researchcancer diagnosiscancer therapycareercareer developmentclinical developmentclinical translationfrontiergender diversitygraduate studentimmunoregulationin vivoinformal supportinnovationmaterials sciencemeetingsnanomaterialsnanomedicinenext generationpostersprogramssocialsuccesssymposiumtranslational studytrendtumortumor microenvironmentunpublished works
项目摘要
Abstract
The 2023 Cancer Nanotechnology Gordon Research Conference (CN-GRC) provides a unique and highly
acclaimed forum where scientists at every stage of their career can share unpublished, innovative cancer
research made possible by the use of nanotechnology. Held biennially since 2011, the conference has had a
strong and steadily growing attendance. To further support the emerging generation of scientists in this field,
the Cancer Nanotechnology Gordon Research Seminar (CN-GRS) will be carried out in conjunction with the
GRC, highlighting talks by graduate students and postdocs. This conference is an important venue bringing
together chemists, physicists, engineers, biologists, clinicians, industry leaders and regulatory experts focused
on the highly interdisciplinary science of cancer nanotechnology. This meeting will particularly focus on two
ends of the spectrum in cancer research: deepening our fundamental understanding of the interactions of
nanomaterials with tumors and the in vivo environment, and translation of cancer nanotechnology out of the lab
and into the clinic.
The conference will bring together a lively group of exceptional scientists to peaceful and scenic Waterville
Valley, NH in order to: 1) share cutting-edge research in cancer nanotechnology by experts representing the
whole spectrum of life sciences; 2) foster discussion, exchange of ideas, and promote collaborations and 3)
enhance the training and development of young scientists and promote diversity. A high priority of the CN-GRC
and CN- GRS is to increase the diversity of participants. Towards this goal, funds are requested for travel and
registration support of female and under-represented speaker
抽象的
2023年的癌症纳米技术戈登研究会议(CN-GRC)提供了独特而高度的
著名的论坛,科学家在职业生涯的每个阶段都可以分享未发表的创新癌症
通过使用纳米技术使研究成为可能。自2011年以来举行了两年一度的会议,会议有一个
强大而稳定增长的出勤率。为了进一步支持该领域的新兴科学家,
癌症纳米技术戈登研究研讨会(CN-GRS)将与
GRC,强调研究生和博士后的会谈。这次会议是一个重要的场所
化学家,物理学家,工程师,生物学家,临床医生,行业领导者和监管专家聚焦
关于癌症纳米技术的高度跨学科科学。这次会议将特别关注两个
癌症研究的范围的末端:加深我们对
具有肿瘤和体内环境的纳米材料,以及癌症纳米技术的翻译
并进入诊所。
该会议将汇集一群热闹的杰出科学家,并为和平而风景秀丽的沃特维尔(Waterville)
新罕布什尔州谷,以下:1)代表专家分享癌症纳米技术方面的尖端研究
整个生命科学; 2)培养讨论,思想交流和促进合作以及3)
增强年轻科学家的培训和发展并促进多样性。 CN-GRC的高度优先级
CN-GRS是增加参与者的多样性。为了实现这一目标,要求资金进行旅行和
女性和代表性不足的演讲者的注册支持
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Darrell J Irvine其他文献
Darrell J Irvine的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Darrell J Irvine', 18)}}的其他基金
"Extended dosing" immunization to enhance humoral immunity to next-generation vaccines
“延长剂量”免疫增强对下一代疫苗的体液免疫
- 批准号:
10638732 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Localized immunotherapy using alum-binding therapeutics
使用明矾结合疗法的局部免疫疗法
- 批准号:
10495228 - 财政年份:2021
- 资助金额:
$ 0.5万 - 项目类别:
Localized immunotherapy using alum-binding therapeutics
使用明矾结合疗法的局部免疫疗法
- 批准号:
10686236 - 财政年份:2021
- 资助金额:
$ 0.5万 - 项目类别:
Localized immunotherapy using alum-binding therapeutics
使用明矾结合疗法的局部免疫疗法
- 批准号:
10367044 - 财政年份:2021
- 资助金额:
$ 0.5万 - 项目类别:
Enhancing CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor
通过嵌合受体加强疫苗增强 CAR-T 细胞对抗实体瘤的活性
- 批准号:
10540783 - 财政年份:2020
- 资助金额:
$ 0.5万 - 项目类别:
Enhancing CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor
通过嵌合受体加强疫苗增强 CAR-T 细胞对抗实体瘤的活性
- 批准号:
10322393 - 财政年份:2020
- 资助金额:
$ 0.5万 - 项目类别:
SpongeBot: genetically engineered cells to suppress SARS-CoV-2 and future viruses
SpongeBot:基因工程细胞抑制 SARS-CoV-2 和未来病毒
- 批准号:
10186867 - 财政年份:2020
- 资助金额:
$ 0.5万 - 项目类别:
Targeted delivery of cytopathicity enhancing agents, and co-ordination with shock and kill, to reduce HIV reservoirs
有针对性地递送细胞病变增强剂,并与休克和杀伤相配合,以减少艾滋病毒储存库
- 批准号:
10207378 - 财政年份:2019
- 资助金额:
$ 0.5万 - 项目类别:
Targeted delivery of cytopathicity enhancing agents, and co-ordination with shock and kill, to reduce HIV reservoirs
有针对性地递送细胞病变增强剂,并与休克和杀伤相配合,以减少艾滋病毒储存库
- 批准号:
10447148 - 财政年份:2019
- 资助金额:
$ 0.5万 - 项目类别:
Targeted delivery of cytopathicity enhancing agents, and co-ordination with shock and kill, to reduce HIV reservoirs
有针对性地递送细胞病变增强剂,并与休克和杀伤相配合,以减少艾滋病毒储存库
- 批准号:
10656269 - 财政年份:2019
- 资助金额:
$ 0.5万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
International Conference on Cancer Health Disparities
国际癌症健康差异会议
- 批准号:
10606212 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Facility Management, Maintenance and Operation Core
设施管理、维护和运营核心
- 批准号:
10793908 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Vascular Biology 2023 - Annual Meeting of the North American Vascular Biology Organization
血管生物学 2023 - 北美血管生物学组织年会
- 批准号:
10754000 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Transposable Elements at the Crossroads of Evolution, Health and Disease
处于进化、健康和疾病十字路口的转座元件
- 批准号:
10750852 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别: